End-of-day quote
Korea S.E.
03:30:00 27/06/2024 am IST
|
5-day change
|
1st Jan Change
|
2,325
KRW
|
+0.22%
|
|
-3.93%
|
-14.84%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,17,723
|
1,39,252
|
2,68,717
|
3,42,794
|
2,30,756
|
2,25,794
|
Enterprise Value (EV)
1 |
1,20,187
|
1,59,262
|
2,65,722
|
3,39,528
|
2,62,823
|
1,47,538
|
P/E ratio
|
-85.2
x
|
39.9
x
|
-11.6
x
|
57.6
x
|
14
x
|
98.5
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.65
x
|
2.55
x
|
3.9
x
|
4.23
x
|
7.61
x
|
2.71
x
|
EV / Revenue
|
2.7
x
|
2.92
x
|
3.85
x
|
4.19
x
|
8.67
x
|
1.77
x
|
EV / EBITDA
|
16.8
x
|
26.9
x
|
15.9
x
|
17.9
x
|
41.5
x
|
7.59
x
|
EV / FCF
|
-13.1
x
|
-14.1
x
|
23.2
x
|
36.9
x
|
-4.68
x
|
5
x
|
FCF Yield
|
-7.62%
|
-7.07%
|
4.3%
|
2.71%
|
-21.4%
|
20%
|
Price to Book
|
2.19
x
|
1.87
x
|
3.4
x
|
3.01
x
|
1.65
x
|
1.27
x
|
Nbr of stocks (in thousands)
|
57,426
|
64,469
|
73,220
|
79,535
|
82,708
|
82,708
|
Reference price
2 |
2,050
|
2,160
|
3,670
|
4,310
|
2,790
|
2,730
|
Announcement Date
|
20/03/19
|
18/03/20
|
22/03/21
|
22/03/22
|
22/03/23
|
21/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
44,446
|
54,585
|
68,947
|
80,964
|
30,319
|
83,215
|
EBITDA
1 |
7,136
|
5,919
|
16,686
|
18,985
|
6,337
|
19,450
|
EBIT
1 |
4,058
|
1,168
|
11,408
|
13,405
|
1,204
|
14,985
|
Operating Margin
|
9.13%
|
2.14%
|
16.55%
|
16.56%
|
3.97%
|
18.01%
|
Earnings before Tax (EBT)
1 |
-1,204
|
4,467
|
-18,608
|
11,900
|
-8,791
|
26,711
|
Net income
1 |
-1,354
|
3,347
|
-21,412
|
5,719
|
16,128
|
2,305
|
Net margin
|
-3.05%
|
6.13%
|
-31.06%
|
7.06%
|
53.19%
|
2.77%
|
EPS
2 |
-24.05
|
54.16
|
-317.0
|
74.85
|
199.0
|
27.71
|
Free Cash Flow
1 |
-9,153
|
-11,260
|
11,436
|
9,209
|
-56,173
|
29,487
|
FCF margin
|
-20.59%
|
-20.63%
|
16.59%
|
11.37%
|
-185.28%
|
35.44%
|
FCF Conversion (EBITDA)
|
-
|
-
|
68.54%
|
48.51%
|
-
|
151.6%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
161.03%
|
-
|
1,279.41%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
20/03/19
|
18/03/20
|
22/03/21
|
22/03/22
|
22/03/23
|
21/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
2,464
|
20,010
|
-
|
-
|
32,067
|
-
|
Net Cash position
1 |
-
|
-
|
2,995
|
3,266
|
-
|
78,256
|
Leverage (Debt/EBITDA)
|
0.3452
x
|
3.381
x
|
-
|
-
|
5.06
x
|
-
|
Free Cash Flow
1 |
-9,153
|
-11,260
|
11,436
|
9,209
|
-56,173
|
29,487
|
ROE (net income / shareholders' equity)
|
-4.4%
|
5.5%
|
-20.2%
|
8.1%
|
3.84%
|
3.88%
|
ROA (Net income/ Total Assets)
|
2.22%
|
0.54%
|
4.67%
|
4.64%
|
0.35%
|
3.65%
|
Assets
1 |
-60,876
|
6,17,468
|
-4,58,895
|
1,23,213
|
46,09,203
|
63,158
|
Book Value Per Share
2 |
937.0
|
1,153
|
1,080
|
1,433
|
1,692
|
2,153
|
Cash Flow per Share
2 |
232.0
|
173.0
|
258.0
|
239.0
|
31.90
|
748.0
|
Capex
1 |
6,355
|
6,965
|
5,440
|
2,042
|
1,001
|
1,568
|
Capex / Sales
|
14.3%
|
12.76%
|
7.89%
|
2.52%
|
3.3%
|
1.88%
|
Announcement Date
|
20/03/19
|
18/03/20
|
22/03/21
|
22/03/22
|
22/03/23
|
21/03/24
|
|
1st Jan change
|
Capi.
|
---|
| -14.84% | 14Cr | | +13.34% | 13TCr | | -9.23% | 1.08TCr | | -17.54% | 717.44Cr | | -34.08% | 402.08Cr | | +8.31% | 343.86Cr | | -20.17% | 246.34Cr | | -16.33% | 195.8Cr | | -24.61% | 167Cr | | -36.56% | 146.67Cr |
Medical Devices & Implants
|